Lupin enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


90,192	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
7,745	7,745	2,603	1,830	1,672
65.1	65.1	90.9	83.2	78.3
5,910	5,910	5,077	2,670	4,244
88,422	—	—	—	—
−1,835	−1,835	2,474	840	2,572
₹1,934.00	—	—	—	—

28,424	28,424	22,371	17,043	16,787
20.8%	20.8%	22.7%	15.7%	25.3%
0.07×	—	—	—	—

2.95×	—	—	—	—
9.27×	—	—	—	—
11.04×	—	—	—	—
16.10×	—	—	—	—
29,967	27,958	22,708	20,011	16,642
9,538	8,816	5,283	3,811	1,798
8,009	7,441	4,114	2,614	917
—	7,546	430	3,490	1,934
5,491	5,491	−1,252	2,562	435
—	5,411	−1,293	2,505	350
—	2,055	1,682	929	1,500

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA CIPLA DRREDDY ALKEM FORTIS AUROPHARMA LAURUSLABS MANKINDMcap ₹90,192 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	90,191.8
- Cash, Equiv & ST Investments	1,671.6	1,830.2	2,602.8	7,744.9	7,744.9
+ Minority Interest	78.3	83.2	90.9	65.1	65.1
+ Total Debt	4,244.1	2,669.9	5,076.7	5,910.2	5,910.2
Enterprise Value	—	—	—	—	88,422.3
Net Debt (memo)	2,572.5	839.7	2,473.9	-1,834.7	-1,834.7
EV per Share	—	—	—	—	1,934.00

Total Capital	16,786.9	17,043.4	22,371.0	28,423.6	28,423.6
Total Debt/Total Capital	25.28	15.67	22.69	20.79	20.79
Total Debt/EV	—	—	—	—	0.07

EV/Sales	—	—	—	—	2.95
EV/EBITDA	—	—	—	—	9.27
EV/EBIT	—	—	—	—	11.04
EV/Free Cash Flow	—	—	—	—	16.10
Reference Items — Trailing FY Values
Sales	16,641.7	20,010.8	22,707.9	27,958.0	29,966.6
EBITDA	1,798.1	3,810.5	5,283.3	8,816.0	9,538.3
EBIT	917.4	2,613.7	4,114.1	7,440.5	8,008.9
Operating Cash Flow	1,934.1	3,490.4	429.9	7,545.6	—
Free Cash Flow	434.5	2,561.5	-1,252.5	5,490.8	5,490.8
FCFF (free cash flow to the firm)	349.6	2,504.7	-1,293.0	5,411.0	—
Capital Expenditure	1,499.6	928.9	1,682.4	2,054.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.